Abstract:Prostate cancer is associated with high mortality and new therapeutic strategies are necessary for improved patient outcome. The utilisation of potent, sequence-specific small interfering RNA (siRNA) to facilitate down-regulation of complementary mRNA sequences in vitro and in vivo has stimulated the development of siRNA-based cancer therapies. However, the lack of an effective siRNA delivery system significantly retards clinical application. Amphiphilic polycations with ‘stealth’ capacity have previously been synthesised by PEGylation of poly-l-lysine-cholic acid (PLL-CA). The benzoic imine linker between PEG and PLL-CA was designed to be stable at physiological pH but cleavable at lower pHs, consistent with the extracellular environment of tumours and the interior of endosomes/lysosomes. The selective hydrolysis of the PEG linker at these targeted sites should provide enhanced cellular uptake and endosomal escape while simultaneously ensuring prolonged blood circulation times. In this study, physicochemical profiling demonstrated nano-complex formation between the PLL derivatives and siRNA (200–280nm in diameter). At physiological pH only a slight cationic surface charge (<20mV) was detected, due to the masking effect of the PEG. In contrast, significantly higher positive charges (∼20 to 30mV and >40mV) were detected upon hydrolysis of the PEG linker at acidic pHs (pH=6.8 and 5.5, respectively). The PEGylated complexes were stable in serum without significant aggregation or decomplexation of siRNA for up to 48h. At the cellular level, PEG–PLLs were comparable with the commercial carrier INTERFRin™, in terms of cellular uptake, endosomal escape and in vitro reporter gene knockdown. In vivo, utilising a mouse model grafted with prostate carcinoma, significant tumour suppression was achieved using PEGylated complexes without marked toxicity or undesirable immunological response, this was accompanied by a simultaneous reduction in target mRNA levels. In summary, the advantages of these vectors include: the in vitro and in vivo silencing efficiency, and the low toxicity and immunogenicity.

Self-assembly of Amphiphilic Phospholipid Peptide Dendrimer-Based Nanovectors for Effective Delivery of Sirna Therapeutics in Prostate Cancer Therapy

Amphiphilic Peptide Dendrimer-Based Nanovehicles for Safe and Effective Sirna Delivery

A Dual Targeting Dendrimer-Mediated Sirna Delivery System for Effective Gene Silencing in Cancer Therapy.

PAMAM Dendrimers Mediate Sirna Delivery to Target Hsp27 and Produce Potent Antiproliferative Effects on Prostate Cancer Cells.

Dendrimer Nanovectors for Sirna Delivery

Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system.

Efficient Delivery Of Sticky Sirna And Potent Gene Silencing In A Prostate Cancer Model Using A Generation 5 Triethanolamine-Core Pamam Dendrimer

Adaptive Amphiphilic Dendrimer‐Based Nanoassemblies As Robust and Versatile Sirna Delivery Systems

Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer.

Molecular Engineering of Dendrimer Nanovectors for Sirna Delivery and Gene Silencing

An ionizable supramolecular dendrimer nanosystem for effective siRNA delivery with a favorable safety profile

Ph-Responsive Complexes Using Prefunctionalized Polymers for Synchronous Delivery of Doxorubicin and Sirna to Cancer Cells

Multifunctional Envelope-Type Sirna Delivery Nanoparticle Platform for Prostate Cancer Therapy.

The Ph-Triggered Triblock Nanocarrier Enabled Highly Efficient Sirna Delivery for Cancer Therapy

Biodegradable Multiamine Polymeric Vector for Sirna Delivery.

Multi-functional Self-Assembled Nanoparticles for Pvegf-Shrna Loading and Anti-Tumor Targeted Therapy.

Smart Nanoparticles Assembled by Endogenous Molecules for Sirna Delivery and Cancer Therapy Via CD44 and EGFR Dual-Targeting

Polycation-detachable Nanoparticles Self-Assembled from Mpeg-Pcl-g-ss-pdmaema for in Vitro and in Vivo Sirna Delivery.

A Biodegradable Amphiphilic and Cationic Triblock Copolymer for the Delivery of Sirna Targeting the Acid Ceramidase Gene for Cancer Therapy

Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

Efficient siRNA Delivery Using a Polyamidoamine Dendrimer with a Modified Pentaerythritol Core